American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer | Zendy

J. Douglas Rizzo | Zendy; Melissa Brouwers | Zendy; Patricia A. Hurley | Zendy; Jerome Seidenfeld | Zendy; Murat O. Arcasoy | Zendy; Jerry L. Spivak | Zendy; C. L. Bennett | Zendy; Julia Bohlius | Zendy; Darren M. Evanchuk | Zendy; Matthew J. Goode | Zendy; Ann A. Jakubowski | Zendy; David H. Regan | Zendy; Mark R. Somerfield | Zendy

Open Access

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

Author(s) -

J. Douglas Rizzo,

Melissa Brouwers,

Patricia A. Hurley,

Jerome Seidenfeld,

Murat O. Arcasoy,

Jerry L. Spivak,

C. L. Bennett,

Julia Bohlius,

Darren M. Evanchuk,

Matthew J. Goode,

Ann A. Jakubowski,

David H. Regan,

Mark R. Somerfield

Publication year - 2010

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2010.29.2201

Subject(s) - medicine , guideline , adverse effect , anemia , darbepoetin alfa , clinical trial , hematology , intensive care medicine , cancer , medline , chemotherapy , cochrane library , randomized controlled trial , oncology , pathology , political science , law

To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research